
News|Articles|May 24, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, May 24, 2022, at 2:45 PM, EDT:
46.6% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
• 66.6% of total US population
• 70.8% of US population aged ≥5 years
• 75% of US population aged ≥12 years
• 76.5% of US population aged ≥18 years
• 90.9% of US population aged ≥65 years
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, May 24, 2022 at 4:20 PM, EDT, there have been:
• 83 481 518 confirmed cases and
• 1 002 624 deaths
• 1 002 624 deaths
In the past 28 days, the 3 states with the most new cases are:
1. California: 251 591
2. New York: 249 937
3. Florida: 159 060
2. New York: 249 937
3. Florida: 159 060
Deaths: California has the highest number of deaths due to COVID-19 with 91 142 reported fatalities, followed by Texas with 88 316 and Florida with 74 374.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 526 486 525 confirmed cases, 6 279 671 deaths, and 11 480 396 810 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials
2
Lilly's Novel Oral GLP-1 Orforglipron Shows Superior Efficacy in 2 Phase 3 Trials
3
Three GLP-1 Receptor Agonists Show Comparable Cardiorenal Protection in Large US Cohort with T2D
4
Abdominal Aortic Aneurysm Management: From Detection to Referral and Ongoing Surveillance
5